Access cutting-edge rare histiocytic disorders (rhds) treatment through this clinical trial at a research site in Madera. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Madera location
Preparing your pre-screening questions…
Access rare histiocytic disorders (rhds) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related rare histiocytic disorders (rhds) treatment provided free
Check if you qualify for this rare histiocytic disorders (rhds) clinical trial in Madera, CA
No-Cost Study Care
Local to Madera
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The rare histiocytic disorders (RHDs) are characterized by the infiltration of one or more organs by non-LCH histiocytes. They can range from localized disease that resolves spontaneously, to progressive disseminated forms that can be sometimes life-threatening. Since they are extremely rare, there is limited understanding of their causes and best treatment options. Physicians, patients and parents of children with RHDs frequently consult members of the Histiocyte Society regarding the best management of these disorders. Very often, no specific recommendation can be made due to the lack of prospective outcome data, or even large retrospective case series. The creation of an international rare histiocytic disorders registry (IRHDR) could facilitate a uniform diagnosis of the RHDs, as well as the collection and analysis of the clinical, epidemiological, treatment and survival data of patients with RHD. The registry may also lead to future therapeutic recommendations, provide a framework for future clinical trials and create excellent research opportunities.
Sponsor: The Hospital for Sick Children
Yes, this clinical trial (NCT02285582) has an active research site in Madera, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for rare histiocytic disorders (rhds) treatment options in Madera, CA, this clinical trial (NCT02285582) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Madera research site is actively enrolling participants for this clinical trial. You'll receive care from experienced rare histiocytic disorders (rhds) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all rare histiocytic disorders (rhds) clinical trials near you to find additional studies recruiting in your area.
See all huntingtons disease clinical trials recruiting in Madera — not just this study.
Browse Huntingtons Disease Trials in Madera →